Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1007/s11274-022-03407-0


Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Galecio Naranjo, Juan Sebastian | - |
dc.contributor.author | Escudero Pastor, Elisa | - |
dc.contributor.author | Corrales, Juan Carlos | - |
dc.contributor.author | García-Romero, Edgar | - |
dc.contributor.author | Fe, Christian de la | - |
dc.contributor.author | Hernandis Belenguer, Verónica | - |
dc.contributor.author | Marín Carrillo, Pedro | - |
dc.date.accessioned | 2025-01-28T11:59:14Z | - |
dc.date.available | 2025-01-28T11:59:14Z | - |
dc.date.issued | 2022-09-13 | - |
dc.identifier.citation | World Journal of Microbiology and Biotechnology, 2022, Vol. 38 : 221 | - |
dc.identifier.issn | Print: 0959-3993 | - |
dc.identifier.issn | Electronic: 1573-0972 | - |
dc.identifier.uri | http://hdl.handle.net/10201/149455 | - |
dc.description | © The Author(s) 2022. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This document is the Published Manuscript, version of a Published Work that appeared in final form in World Journal of Microbiology and Biotechnology. To access the final edited and published work see https://doi.org/10.1007/s11274-022-03407-0 | - |
dc.description.abstract | Mastitis is a significant disease in dairy ruminants, causing economic losses to the livestock industry and severe risks to public health. Antibiotic therapy is one of the most crucial practices to treat mastitis, although the susceptibility of caprine mastitis pathogens to current antibiotics has not been tested under standard or modified incubation conditions. This work evaluated the in vitro activity of tildipirosin, gamithromycin, oxytetracycline, and danofloxacin against caprine mastitis pathogens incubated following standard conditions of Clinical and Laboratory Standards Institute (CLSI) and deviation method by 25% supplementation with goat serum. Mycoplasma agalactiae, Escherichia coli, Staphylococcus aureus, Streptococcus spp., and coagulase-negative Staphylococci (CNS) were isolated from dairy goats with mastitis in Spain. Minimum inhibitory concentrations (MICs) were determined using the broth microdilution technique. The lowest MIC90 under standard conditions was obtained with danofloxacin for mastitis-causing pathogens. An exception was M. agalactiae, where danofloxacin and oxytetracycline obtained low values. However, after adding serum, gamithromycin showed the lowest MIC50 for S. aureus, Streptococcus spp., and CNS. The lowest MIC50 was obtained with all the antibiotics tested (< 0.125 µg/ml) against M. agalactiae. Supplementing with serum resulted in a significant variation in tildipirosin and gamithromycin MIC values for CNS, S. aureus, M. agalagtiae, and E. coli. In brief, the MIC for antibiotics used against mastitis should be determined under conditions closely resembling intramammary infections to obtain representative susceptibility patterns against mastitis pathogens. Caprine mastitis pathogens were broadly susceptible to danofloxacin under standard conditions. The potency of macrolides against caprine mastitis pathogens increases when serum is present in culture media. | - |
dc.format | application/pdf | es |
dc.format.extent | 8 | es |
dc.language | eng | es |
dc.publisher | Springer | - |
dc.relation | Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Tildipirosin | - |
dc.subject | Gamithromycin | - |
dc.subject | Oxytetracycline | - |
dc.subject | Danofoxacin | - |
dc.subject | Mastitis | - |
dc.subject | MIC | - |
dc.subject | Mycoplasma agalactiae | - |
dc.subject | Serum | - |
dc.subject | Goats | - |
dc.title | Susceptibility of caprine mastitis pathogens to tildipirosin, gamithromycin, oxytetracycline, and danofloxacin: effect of serum on the in vitro potency of current macrolides | es |
dc.type | info:eu-repo/semantics/article | es |
dc.relation.publisherversion | https://link.springer.com/article/10.1007/s11274-022-03407-0 | - |
dc.identifier.doi | https://doi.org/10.1007/s11274-022-03407-0 | - |
dc.contributor.department | Departamento de Farmacología | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Paper publicado.pdf | 784,26 kB | Adobe PDF | ![]() Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons